Gina Simmons Chapman’s Post

If you'll be attending the 2023 AVBCC Summit in October, you won't want to my colleague Greg Gregory, PhD when he speaks on "Value-Based Agreements: Roadmap from Strategy to Design Through Implementation." Please reach out to either Greg or me if you'd like to discuss VBAs or another market access topic! #marketaccess #strategicconsulting #pharma #biotech

Let me know if you will be at AVBCC - the Precision team looks forward to discussing #oncology #marketaccess #valuebasedcontracting with you! PRECISIONadvisors Precision Value & Health

WATCH: John Shen, MD, discusses features associated w/ the use of the PSMA–directed ADC ARX517 in mCRPC and highlights early efficacy and safety findings with this agent. #oncology #prostatecancer https://lnkd.in/exSPjdrU

CASE STUDY: We helped an #oncology provider group demonstrate its value to prospective investors through a detailed assessment of the regulatory and market landscape. Learn how we approached this #healthpolicy project: https://lnkd.in/e7CumrQa #AvalereInAction

Lin, Chengyu, M.D., Associate Medical Director at MERIT, outlines a common challenge when implementing reader monitoring plans, and how that challenge is addressed. Watch this short video clip to learn more! #MERITCRO #YourClinicalEndpointExpert #oncology #clinicaltrials #clinicalresearch

Listen to Dr. Karine Tawagi shedding light on the need for more diversity in clinical trial enrollment. Let's bridge the gap for more inclusive groundbreaking approvals and change the standard of care. 🌍💪 Listen to the full episode: https://bit.ly/TwoOncDocs #Oncology #OncoAlert #OncEd #ONCOshorts #ClinicalTrial

Did you know? As an NCODA member, you have a wealth of valuable resources at your fingertips! From clinical guidance to educational materials, it's all on our website. Check out the NCODA Resources page and unlock a world of knowledge: https://lnkd.in/gcRr_g7Z #oncology #resources #passionforpatients

Really looking forward to this, off the back of the recent Nature Medicine article - come join us to learn more about the DigiONE pilot, federated analytics to get patient level data equivalent insights and what is ahead

#LatestpublicationofJONT2023 #Title: Beyond Overall Survival: The Value of Oncology- Relevant Endpoints in HTA Body / Payer Decision-Making #checkout: https://lnkd.in/dTjfubNX #Oncology #relevantendpoints #HTAbody #Payer #Decisionmaking #Value #DrugDiscovery #Cancerresearch

Advanced #IRT systems tackle the unique #RTSM challenges #oncology trial sponsors face, ensuring trials stay on track and patients continue treatment, even through unexpected (and some expected) changes. Learn how in this article by Calyx's Malcolm Morrissey. https://lnkd.in/gr2-Bk38 #ClinicalTrials #Randomization #TrialSupplyManagement #CalyxIRT